WALE WATCH

Stocks ended higher in a session that required a strong gastric constitution. Weak employment figures from ADP heightened recession fears sending stocks lower. Fears were compounded by confusion over tariffs; fears were ultimately quelled by reports that automakers would get a one-month hold on auto tariffs.

($HZO) HZO

MarineMax (HZO) reported fiscal Q1 2025 earnings of $0.17per share, beating estimates of -$0.14, despite revenue declining 11.2%year-over-year to $468.5 million. The company reaffirmed its fiscal year 2025 guidance, expecting adjusted net income of $1.80 to $2.80 per diluted share. Analysts maintain a consensus "Strong Buy" rating on HZO stock, with an average price target of $38.33, representing a 43.13% upside from current levels.

($INSP) INSP

Inspire Medical Systems (INSP) reported strong Q4 2024earnings, with EPS of $1.15 beating estimates of $0.74 and revenue of $239.76million. Analysts remain bullish on INSP, with a consensus "ModerateBuy" rating and an average price target of $228.82, representing a 28.33%upside from the current price. The company provided 2025 EPS guidance of $2.10to $2.20 per share, indicating continued growth expectations.

($OSIS) OSIS

OSI Systems (NASDAQ: OSIS) reported record-breaking second quarter results for fiscal 2025, with revenues reaching $419.8 million, marking 12% increase year-over-year, and net income rising to $37.8 million, or $2.22 per diluted share. Based on strong performance, the company increased its fiscal 2025 guidance, now projecting revenues between $1.685-$1.710 billion(9.5-11.1% growth) and non-GAAP diluted EPS of $9.10-$9.40 (11.9-15.6% growth).Following the earnings report, analysts at Roth MKM and Oppenheimer boosted their price targets for OSIS to $224 and $225, respectively, maintaining their positive ratings on the stock.

($RH) RH

RH's stock has been under pressure as analysts at Wedbush lowered their FY2025 earnings estimates for the company, forecasting EPS of$4.33 compared to the consensus estimate of $4.39. The broader market experienced volatility last week, with the S&P 500 briefly erasing its year-to-date gains, driven lower by mega-cap tech stocks. RH's next earnings report is scheduled for March 26, 2025, with analysts expecting EPS of $1.90,which would represent a decrease from the previous quarter.

‍

($SPHR) SPHR

Sphere Entertainment ($SPHR) reported Q2 2025 earnings, missing EPS estimates with a loss of $3.49 per share but beating revenue expectations with $308.3 million. JPMorgan lowered its price target for SPHR from $57 to $54 while maintaining an "overweight" rating. The stock has received a consensus "Hold" rating from analysts, with an average price target of $47.75, representing a 10.39% upside from the current price.

($KPTI) KPTI

Karyopharm Therapeutics (KPTI) stock reached a new 52-weeklow of $6.37 on March 4, 2025, amid challenging market conditions and concerns over the company's cash burn rate. HC Wainwright analysts reduced their Q1 2025earnings per share estimates for KPTI to -$4.37, down from their previous estimate of -$4.35, while maintaining a "Buy" rating and a $56.00price target on the stock. Despite the recent downturn, RBC Capital analyst Brian Abrahams maintained a Buy rating on KPTI with a price target of $45.00 on March 2, 2025.

($GCO) GCO

Genesco Inc. (GCO) is expected to report Q4 and full-year2025 earnings on March 7, 2025, with analysts forecasting earnings of $3.31 per share. The company is projected to show a 6.2% increase in quarterly revenue to$784.85 million compared to the same period last year. Genesco's stock has a current average analyst rating of "hold" with a median 12-month price target of $40.00, above its last closing price of $32.97.

($JOUT) JOUT

Johnson Outdoors (JOUT) received a consensus rating of Buyfrom analysts, with 2 analysts giving the stock a Buy rating and an averageprice target of $39.50 for 2025. Sidoti Csr analyst A. Lebiedzinski raised Q32025 earnings per share estimates for Johnson Outdoors, now expecting thecompany to post earnings of $0.80 per share for the quarter, up from theirprevious estimate of $0.79. The company is scheduled to report its nextquarterly earnings results on May 02, 2025.

($KRRO) KRRO

Korro Bio (KRRO) reported positive results for its leadproduct KRRO-110, demonstrating improved editing efficiency from 50% to 60% andincreased healthy protein production. The company's stock has a consensus"Buy" rating from 7 Wall Street analysts, with an average pricetarget of $144.00, representing a potential 560.85% upside from the currentprice. However, KRRO's stock price has fallen in 6 of the last 10 days, down13.79% for this period, and analysts expect it to decline further by 39.77%over the next 3 months.

($AIRS) AIRS

AirSculpt Technologies (AIRS) is expected to report its Q42024 earnings on February 25, 2025, with analysts estimating an EPS of $0.04and revenue of $44.25 million. The stock currently has a consensus"Hold" rating from 5 analysts, with a price target of $5.00,representing a potential 21.95% upside from the current price. Recent insidertrading activity shows executives selling shares, with the Executive Chairmanand Interim CEO/CFO selling a combined 163,820 shares over the past 6 months.

‍